---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-020666"
form_type: "8-K"
ticker: "GCAN"
cik: "0001695473"
company_name: "Greater Cannabis Company, Inc."
filed_at: "2021-08-19T23:59:59+00:00"
generated_at: "2026-06-29T08:57:19.033722+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# GCAN signs licensing/research deal with Shaare Zedek for cannabinoid therapy targeting neuropsychiatric disorders

## Summary
- Licensing covers novel cannabinoid therapeutic for autism, schizophrenia, Parkinson's, Alzheimer's, and other neuropsychiatric disorders.
- Joint R&D agreement with Shaare Zedek Scientific, technology transfer arm of Jerusalem's Shaare Zedek Medical Center.
- Dr. Adi Aran, SZMC pediatric neurology director and cannabis research pioneer, will lead continued clinical program.
- Director David Tavor resigned effective August 19, 2021.
- No financial terms of the agreements were disclosed.

## SEC filing metadata
- accession: 0001493152-21-020666
- form_type: 8-K
- ticker: GCAN
- cik: 0001695473
- company_name: Greater Cannabis Company, Inc.
- filed_at: 2021-08-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1695473/000149315221020666/0001493152-21-020666-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1695473/000149315221020666/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-020666
- JSON: https://secwatch.observer/filing/0001493152-21-020666.json
- Plain text: https://secwatch.observer/filing/0001493152-21-020666.txt

## Key facts
- Executive change
  David Tavor resigned as director at Greater Cannabis Company, Inc..
  - Action: resigned
  - Role: director
  source text: Effective August 19, 2021, David Tavor resigned as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1695473/000149315221020666/0001493152-21-020666-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.